Key result
Delaying elective noncardiac surgery for at least 6 weeks after bare-metal stent and 1 year after drug-eluting stent implantation is recommended to reduce perioperative major adverse cardiac events.
Why the study?
What is the optimal timing of elective noncardiac surgery and how should antiplatelet therapy be managed in patients with recently implanted coronary stents?
What is the optimal timing of elective noncardiac surgery and how should antiplatelet therapy be managed in patients with recently implanted coronary stents?
No takes yet. Share an insight, caveat, or question.
Delaying elective noncardiac surgery after coronary stenting and carefully managing antiplatelet therapy is crucial to balance the risks of stent thrombosis and surgical bleeding.
Rade et al. (2008) conducted an editorial in Coronary artery stents requiring noncardiac surgery. Timing of noncardiac surgery and antiplatelet therapy was evaluated. Delaying elective noncardiac surgery for at least 6 weeks after bare-metal stent and 1 year after drug-eluting stent implantation is recommended to reduce perioperative major adverse cardiac events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: